SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 7,963.77 |
Enterprise Value ($M) | 6,755.94 |
Book Value ($M) | 5,580.04 |
Book Value / Share | 7.67 |
Price / Book | 1.43 |
NCAV ($M) | 5,175.13 |
NCAV / Share | 7.11 |
Price / NCAV | 1.54 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.81 |
Return on Assets (ROA) | 0.66 |
Return on Equity (ROE) | 0.73 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 10.37 |
Current Ratio | 10.43 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5,801.12 |
Assets | 6,206.03 |
Liabilities | 625.99 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Viking Global Investors Lp | 7.30 | -22.01 | |
13G | Fmr Llc | 6.64 | ||
13G/A | Vanguard Group Inc | 5.63 | 0.00 | |
13G | BlackRock, Inc. | 5.70 | 0.00 | |
13G/A | Sumitomo Chemical Co., Ltd. | 0.00 | -100.00 | |
13G/A | QVT Financial LP | 8.28 | -40.72 | |
13G/A | Dexcel Pharma Technologies Ltd. | 12.78 | 0.00 | |
13G/A | Ramaswamy Vivek | 9.75 | 0.00 | |
13G/A | Sb Investment Advisers (uk) Ltd | 9.10 | -23.15 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
689,822 | 3,003,674 | 22.97 | |
1,210,493 | 4,854,810 | 24.93 | |
1,184,166 | 5,235,107 | 22.62 | |
893,963 | 5,807,350 | 15.39 | |
(click for more detail) |
Similar Companies | |
---|---|
RIGL – Rigel Pharmaceuticals, Inc. | RLMD – Relmada Therapeutics, Inc. |
RLYB – Rallybio Corporation | RPRX – Royalty Pharma plc |
RPTX – Repare Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io